Brent Neidig - 07 Feb 2022 Form 4 Insider Report for USANA HEALTH SCIENCES INC (USNA)

Role
Chief Officer & MD of China
Signature
Joshua Foukas, as attorney in fact.
Issuer symbol
USNA
Transactions as of
07 Feb 2022
Net transactions value
-$61,106
Form type
4
Filing time
10 Feb 2022, 14:03:34 UTC
Previous filing
08 Feb 2022
Next filing
29 Apr 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction USNA Common Stock Options Exercise +1,459 +84% 3,194 08 Feb 2022 Direct F1
transaction USNA Common Stock Tax liability $61,106 -648 -20% $94.30 2,546 08 Feb 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction USNA Restricted Stock Units Award $0 +5,606 +50% $0.000000 16,711 07 Feb 2022 Common Stock 5,606 Direct F1, F3
transaction USNA Restricted Stock Units Options Exercise $0 -1,459 -8.7% $0.000000 15,252 08 Feb 2022 Common Stock 1,459 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of USNA common stock.
F2 Restricted Stock Units vest 25% on the anniversary of February 8th, 2021.
F3 On February 7th, 2022, the reporting person was granted restricted stock units, vesting at 25% on each 7th of February thereafter.